Currently, there are 191.10M common shares owned by the public and among those 189.18M shares have been available to trade.
The company’s stock has a 5-day price change of 13.84% and 33.79% over the past three months. CHX shares are trading 33.79% year to date (YTD), with the 12-month market performance up to 48.20% higher. It has a 12-month low price of $24.98 and touched a high of $38.37 over the same period. CHX has an average intraday trading volume of 1.45 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 17.64%, 27.43%, and 22.27% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of ChampionX Corp. (NASDAQ: CHX) shares accounts for 104.89% of the company’s 191.10M shares outstanding.
It has a market capitalization of $7.47B and a beta (3y monthly) value of 2.47. The stock’s trailing 12-month PE ratio is 24.84, while the earnings-per-share (ttm) stands at $1.57. The company has a PEG of 1.19 and a Quick Ratio of 1.15 with the debt-to-equity ratio at 0.42. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.66% over the week and 2.30% over the month.
Analysts forecast that ChampionX Corp. (CHX) will achieve an EPS of $0.41 for the current quarter, $0.47 for the next quarter and $2.4 for 2025. The lowest estimate earnings-per-share for the quarter is $0.39 while analysts give the company a high EPS estimate of $0.43. Comparatively, EPS for the current quarter was $0.36 a year ago. Earnings per share for the fiscal year are expected to increase by 10.10%, and 22.45% over the next financial year. EPS should grow at an annualized rate of 20.90% over the next five years, compared to 5.66% over the past 5-year period.
Looking at the support for the CHX, a number of firms have released research notes about the stock. Piper Sandler stated their Neutral rating for the stock in a research note on January 08, 2024, with the firm’s price target at $38-$32. Barclays coverage for the ChampionX Corp. (CHX) stock in a research note released on October 17, 2023 offered a Overweight rating with a price target of $42. CapitalOne was of a view on July 14, 2023 that the stock is Overweight, while Barclays gave the stock Equal Weight rating on October 06, 2022, issuing a price target of $38- $28. The Benchmark Company on their part issued Buy rating on August 25, 2022.
